4//SEC Filing
Barnes Alane P 4
Accession 0000882796-25-000033
CIK 0000882796other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:13 PM ET
Size
6.4 KB
Accession
0000882796-25-000033
Insider Transaction Report
Form 4
Barnes Alane P
VP, General Counsel & Corp Sec
Transactions
- Tax Payment
Common Stock
2025-12-12$7.57/sh−8,540$64,648→ 336,936 total - Sale
Common Stock
2025-12-15$7.65/sh−21,210$162,257→ 315,726 total
Footnotes (2)
- [F1]Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person.
- [F2]This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001584348
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:13 PM ET
- Size
- 6.4 KB